Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Recruiting · NCT06499857 · Registry updated 2025-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation | Arrhythmias, Cardiac, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2025-11-14 | NCT06499857 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of Arizona College of Medicine- Phoenix | Phoenix | United States | 1 |
| University of Chicago | Chicago | United States | 312 |